SCHEMBL4900796

SCHEMBL4900796

CCN(Sc1nc2ccccc2s1)S(=O)(=O)c1cc(C)c(C)c(C(=O)O)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.43
KMT2A Q03164 3/20 0.43
NPC1 O15118 3/20 0.43
RAB9A P51151 3/20 0.43
SMN1; SMN2 Q16637 3/20 0.42
KDM4E B2RXH2 1/20 0.42
MAPT P10636 3/20 0.42
HTT P42858 1/20 0.42
PTPN1 P18031 1/20 0.41
CYP2C9 P11712 2/20 0.41
GAA P10253 2/20 0.41
CYP3A4 P08684 1/20 0.41
ALDH1A1 P00352 4/20 0.40
HSD17B10 Q99714 3/20 0.40
TSHR P16473 2/20 0.40
MAPK1 P28482 2/20 0.40
BRCA1 P38398 1/20 0.40
ALOX5 P09917 4/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C19 P33261 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4904126 0.90 ALDH1A1 (0.45) NPC1RAB9ASMN1; SMN2KDM4EMAPT
SCHEMBL4906179 0.89 MEN1 (0.44) MEN1KMT2ANPC1RAB9ASMN1; SMN2
SCHEMBL4899670 0.88 PPARA (0.46) SMN1; SMN2ALOX5NPSR1
SCHEMBL4902985 0.86 PPARA (0.49) MEN1KMT2ANPC1RAB9ASMN1; SMN2
SCHEMBL4905500 0.82 NPC1 (0.41) MEN1KMT2ANPC1RAB9ASMN1; SMN2
SCHEMBL4905953 0.81 ALDH1A1 (0.46) MEN1KMT2ANPC1RAB9ASMN1; SMN2
SCHEMBL4902801 0.78 CYP1A2 (0.45) KMT2ASMN1; SMN2CYP2C9CYP3A4ALDH1A1
SCHEMBL4905834 0.78 MAPT (0.39) NPC1RAB9ASMN1; SMN2MAPTALDH1A1
SCHEMBL4904276 0.77 PPARA (0.46) ALOX5
SCHEMBL4906196 0.77 PPARA (0.47) MEN1KMT2ANPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds HAMANAKA ERNEST S 2006-10-12 US disclosed
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARA, PPARG, PPARD MEN1 4859/4885KMT2A 3602/4885NPC1 50/4885
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD MEN1 4855/4885KMT2A 3530/4885NPC1 59/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD MEN1 4855/4885KMT2A 3530/4885NPC1 59/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.